Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial

Cited by (420)

Items 101–200 of 420

1. Role of Cannabinoids in Pain Management
   Ethan B. Russo, Andrea G. Hohmann · 2012 · Springer eBooks
2. Neuropathic cancer pain: What we are dealing with? How to manage it?
   Şuayib Yalçın, Ece Esin · 2014 · OncoTargets and Therapy
3. Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology
   Ilit Turgeman, Gil Bar‐Sela · 2018 · Expert Opinion on Investigational Drugs
4. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs
   Jayesh R. Parmar, Benjamin D. Forrest, Robert A. Freeman · 2015 · Research in Social and Administrative Pharmacy
5. Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis
   Latha Velayudhan, Katie McGoohan, Sagnik Bhattacharyya · 2021 · PLoS Medicine
6. Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
   Uwe Klaus Zettl, Paulus Stefan Rommer, Petra Hipp, Robert Patejdl · 2015 · Therapeutic Advances in Neurological Disorders
7. Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions
   Seulah Choi, Barry C. Huang, Charlene E. Gamaldo · 2019 · Journal of Clinical Neurophysiology
8. An Overview of Pharmacologic Management of Chronic Pain
   Benjamin R. Beal, Mark S. Wallace · 2015 · Medical Clinics of North America
9. Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials
   Igor Dykukha, Rolf Malessa, Ute Essner, Michael A. Ueberall · 2021 · Pain Medicine
10. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
    Ersilia Nigro, Marialuisa Formato, Giuseppina Crescente, Aurora Daniele · 2021 · Molecules
11. Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature
    Shannon Inglet, Bradly Winter, Sarah E. Yost, Sophia Entringer, Anh Lian, Meryl Biksacky, Renee D. Pitt, Whitney Mortensen · 2020 · Annals of Pharmacotherapy
12. Cannabis in Palliative Care: A Systematic Review of Current Evidence
    Marjan Doppen, Stacey M. Kung, Ingrid Maijers, Mary John, Harriette Dunphy, Hermaleigh Townsley, Allie Eathorne, Alex C. Semprini, Irene E. Braithwaite · 2022 · Journal of Pain and Symptom Management
13. Cannabis and cannabinoids in cancer pain management
    Howard Meng, Tianyang Dai, John G. Hanlon, James Downar, Shabbir M.H. Alibhai, Hance A. Clarke · 2020 · Current Opinion in Supportive and Palliative Care
14. Cannabis dosing and administration for sleep: a systematic review
    Rob Velzeboer, Adeeb Malas, Pierre Boerkoel, Katie Cullen, Michelle Hawkins, Jordanna Roesler, Wayne Wei-Ku Lai · 2022 · SLEEP
15. Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
    Marija Darkovska Serafimovska, Tijana Serafimovska, Zorica Arsova‐Sarafinovska, Sasho Stefanoski, Zlatko Keskovski, Trajan Balkanov · 2018 · Journal of Pain Research
16. Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
    Uri Bright, Irit Akirav · 2022 · International Journal of Molecular Sciences
17. Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis
    Jehad Ahmad Barakji, Steven Kwasi Korang, Joshua Buron Feinberg, Mathias Maagaard, Ole Mathiesen, Christian Nyfeldt Gluud, Janus Christian Jakobsen · 2023 · PLoS ONE
18. Medical cannabis: considerations for the anesthesiologist and pain physician
    Pierre Beaulieu, Aline Boulanger, Julie Desroches, Alexander John Clark · 2016 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
19. High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain
    Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, Suzanne Sisley, David A. Williams, Daniel Joseph Clauw · 2019 · Journal of Pain
20. Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
    Cecilia Theresa Costiniuk, Zahra Saneei, Jean‐Pierre Routy, Shari L. Margolese, Enrico Mandarino, Joel Singer, Bertrand Lebouché, Joseph Cox, Jason Szabo, Marie‐Josée Brouillette et al. · 2019 · BMJ Open
21. A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety
    Grant L. Steele, Tom J. Arneson, Dylan Michael Zylla · 2019 · Current Oncology Reports
22. Medicinal cannabis in Thailand: 1-year experience after legalization
    Nantthasorn Zinboonyahgoon, Sahaphume Srisuma, Wirun Limsawart, Andrew S.C. Rice, Chuthamanee C. Suthisisang · 2020 · Pain
23. MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events
    Josephine To, Mellar P. Davis, Andrea Sbrana, Bryony Alderman, David Hui, Sandip Mukhopadhyay, Carole Bouleuc, Amy Allen Case, Koji Amano, Gregory Brian Crawford et al. · 2023 · Supportive Care in Cancer
24. Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals
    Shivika Datta, Praveen Chandrashekarapura Ramamurthy, Uttpal Anand, Simranjeet Singh, Amritpal Singh, Daljeet Singh Dhanjal, Vaishali Dhaka, Sanjay Kumar, Dhriti Kapoor, Samapika Nandy et al. · 2021 · Saudi Journal of Biological Sciences
25. Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks
    Samuel P. Ang, Shawn Sidharthan, Wilson C. Lai, Nasir Hussain, Kiran V. Patel, Amitabh Gulati, Onyeaka Henry, Alan D. Kaye, Vwaire Orhurhu · 2023 · Pain and Therapy
26. Postępowanie w bólu pooperacyjnym 2018 — stanowisko Sekcji Znieczulenia Regionalnego i Terapii Bólu Polskiego Towarzystwa Anestezjologii i Intensywnej Terapii, Polskiego Towarzystwa Znieczulenia Regionalnego i Leczenia Bólu, Polskiego Towarzystwa Badania Bólu oraz Konsultanta Krajowego w dziedzinie anestezjologii i intensywnej terapii
    Hanna Misiołek, Renata Zajączkowska, Andrzej Daszkiewicz, Jarosław Woroń, Jan Dobrogowski, Jerzy Wordliczek, Radosław Owczuk · 2018 · Anaesthesiology Intensive Therapy
27. Cancer Pain Treatment Strategies in Patients with Cancer
    Sebastiano Mercadante · 2022 · Drugs
28. Cannabinoide in der palliativen Versorgung
    Martin Mücke, C. Carter, Henning Cuhls, Magdalena Sarah Prüß, Lukas Radbruch, Winfried Häuser · 2016 · Der Schmerz
29. LC–MS/MS quantitation of phytocannabinoids and their metabolites in biological matrices
    Wessam Hamdy Abd-Elsalam, Muhammad A. Alsherbiny, Janice Yu Chen Kung, David W. Pate, Raimar Löbenberg · 2019 · Talanta
30. Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence
    Shanna L. Babalonis, SHARON L. WALSH · 2020 · European Neuropsychopharmacology
31. Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials
    Longo, Riana, Oudshoorn, Abe, Befus, Deanna · 2021 · Pain Management Nursing
32. Perspectives in veterinary medicine on the use of cannabinoids as complementary palliative therapy for pain in cancer patients
    Cláudia Sampaio Fonseca Repetti, Raul José Silva Gírio, Milena Friolani, Sandra Maria Barbalho · 2019 · Ciência Rural
33. Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients
    Joshua Aviram, Gil Moshe Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmoud Abu Amna, Luiza Akria, Dmitry Goncharov et al. · 2020 · Pharmaceuticals
34. Should doctors prescribe cannabinoids?
    Michael Farrell, Rachelle Buchbinder, Wayne Hall · 2014 · BMJ
35. Natural products as a perspective for cancer pain management: A systematic review
    Daniele Nascimento Gouveia, Adriana Gibara Guimarães, Wagner Barbosa da Rocha Santos, Lucindo José Quintans‐Júnior · 2018 · Phytomedicine
36. Cannabis for Pain and Headaches: Primer
    Philip S. Kim, Michael Alan Fishman · 2017 · Current Pain and Headache Reports
37. Cannabidiol as a Treatment for Mood Disorders: A Systematic Review: Le cannabidiol comme traitement des troubles de l’humeur: une revue systématique
    Jairo Vinícius Pinto, Gayatri Saraf, Christian Frysch, Daniel Vigo, Kamyar Keramatian, Trisha Chakrabarty, Raymond Wing Moon Lam, Marcia Kauer‐Sant’Anna, Lakshmi N. Yatham · 2019 · The Canadian Journal of Psychiatry
38. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
    Michelle Sexton, José M. Garcia, Aminah Jatoi, Carey S. Clark, Mark S. Wallace · 2021 · JNCI Monographs
39. Polypharmacology Shakes Hands with Complex Aetiopathology
    James Brodie, Vincenzo Di Marzo, Geoffrey W. Guy · 2015 · Trends in Pharmacological Sciences
40. The Efficacy of Medical Marijuana in the Treatment of Cancer-Related Pain
    Ian M. Pawasarat, Emily M. Schultz, Justin C. Frisby, Samir D. Mehta, Mark Angelo, Samuel Hardy, Tae Won Benjamin Kim · 2020 · Journal of Palliative Medicine
41. Reporting of Sample Size Calculations in Analgesic Clinical Trials: ACTTION Systematic Review
    Andrew McKeown, Jennifer S. Gewandter, Michael McDermott, Joseph R. Pawlowski, Joseph J. Poli, Daniel Rothstein, John T. Farrar, Ian Gilron, Nathaniel P. Katz, Allison H. Lin et al. · 2014 · Journal of Pain
42. Re-Branding Cannabis: The Next Generation of Chronic Pain Medicine?
    Gregory T. Carter, Simone P. Javaher, Michael H. V. Nguyen, Sharon B. Garrett, Beatriz Helena Carlini · 2014 · Pain Management
43. What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review
    Gabrielle Campbell, Wayne Hall, Suzanne Nielsen · 2018 · International Review of Psychiatry
44. Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain
    Brooke Porter, Barbara St. Marie, Gary Milavetz, Keela Herr · 2021 · Journal of Gerontological Nursing
45. Use of Cannabidiol in the Management of Insomnia: A Systematic Review
    Rylea M. Ranum, Mary O. Whipple, Ivana T. Croghan, Brent Bauer, Loren L. Toussaint, Ann Vincent · 2022 · Cannabis and Cannabinoid Research
46. Are the MORECare guidelines on reporting of attrition in palliative care research populations appropriate? A systematic review and meta-analysis of randomised controlled trials
    Anna Oriani, Lesley Dunleavy, Paul Sharples, Guillermo Pérez Algorta, Nancy J Preston · 2020 · BMC Palliative Care
47. A Secondary Analysis from a Randomized Trial on the Effect of Plasma Tetrahydrocannabinol Levels on Pain Reduction in Painful Diabetic Peripheral Neuropathy
    Mark S. Wallace, Thomas D. Marcotte, Joseph Hampton Atkinson, Hayley Treloar Padovano, Marcel O. Bonn‐Miller · 2020 · Journal of Pain
48. Opioid-sparing effects of cannabinoids: Myth or reality?
    Bernard Le Foll · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
49. Cannabinoids
    Paul D. Howard, Robert Twycross, John L. Shuster, Mary Mihalyo, Andrew Wilcock · 2013 · Journal of Pain and Symptom Management
50. State of the evidence
    Sydney Tateo · 2016 · Journal of the American Association of Nurse Practitioners
51. Randomized, double-blind, placebo-controlled, dose-escalation study: Investigation of the safety, pharmacokinetics, and antihyperalgesic activity of L-4-chlorokynurenine in healthy volunteers
    Mark S. Wallace, Alexander White, Kathy A. Grako, Randal Lane, Allen Cato, H. Ralph Snodgrass · 2017 · Scandinavian Journal of Pain
52. Cannabidiol as an immune modulator: A comprehensive review
    Khizra Mujahid, Muhammad Shahzaib Rasheed, Azka Sabir, Jutaek Nam, Talha Ramzan, Waseem Ashraf, Imran Imran · 2025 · Saudi Pharmaceutical Journal
53. Cannabinoids and cancer pain: A new hope or a false dawn?
    Matthew R. D. Brown, W. Paul Farquhar-Smith · 2018 · European Journal of Internal Medicine
54. Cannabis in End-of-Life Care: Examining Attitudes and Practices of Palliative Care Providers
    Rachel R. Luba, Mitch Earleywine, Stacey L. Farmer, Melissa N. Slavin · 2018 · Journal of Psychoactive Drugs
55. Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis
    Barliz Waissengrin, Dan Mirelman, Sharon Pelles, Felix Bukstein, Deborah T. Blumenthal, Ido Wolf, Ravit Geva · 2021 · Therapeutic Advances in Medical Oncology
56. Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
    Brooks W. Johnson, Natalie H. Strand, John Raynak, Christian Jara, Kisanet Habtegiorgis, Brennan A. Hand, Sang Hong, Jillian A. Maloney · 2025 · Biomedicines
57. Medical marijuana in pediatric oncology: A review of the evidence and implications for practice
    Prasanna Janaki Ananth, Anne E. Reed-Weston, Joanne Wolfe · 2017 · Pediatric Blood & Cancer
58. Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression
    Giulia De Feo, Amy Allen Case, Gregory Brian Crawford, David Hui, Josephine To, Andrea Sbrana, Bryony Alderman, Sandip Mukhopadhyay, Carole Bouleuc, Koji Amano et al. · 2023 · Supportive Care in Cancer
59. Design and conduct of confirmatory chronic pain clinical trials
    Nathaniel P. Katz · 2020 · PAIN Reports
60. The Role of Cannabinoids in Advancing Cancer Treatment: Insights from Evidence-Based Medicine
    Magdalena Skórzewska, Katarzyna Gęca · 2024 · Current Oncology Reports
61. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
    Dayong Lee, Erin L Karschner, Garry Milman, Allan J. Barnes, Robert S. Goodwin, Marilyn Ann Huestis · 2012 · Drug and Alcohol Dependence
62. Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
    Miguel Olivas-Aguirre, Liliana Torres-López, Kathya Villatoro-Gómez, Sonia Mayra Pérez‐Tapia, Igor I. Pottosin, Oxana R. Dobrovinskaya · 2022 · Pharmaceuticals
63. MicroRNA let-7d is a target of cannabinoid CB 1 receptor and controls cannabinoid signaling
    Anna Chiarlone, Christine Börner, Laura Martín-Gómez, Ada Jiménez-González, Adrián García-Concejo, Laura García‐Bermejo, Mar Lorente, Cristina Blázquez, Elena García-Taboada, Amador Haro et al. · 2016 · Neuropharmacology
64. The role of cannabinoids in pain control: the good, the bad, and the ugly
    Joseph V. Pergolizzi, Jo Ann LeQuang, Robert Taylor, Robert B. Raffa, Daniel R. Colucci · 2018 · Minerva Anestesiologica
65. Use of Cannabis and Cannabinoids in Patients With Cancer
    Lindsey Sawtelle, Lisa M. Holle · 2020 · Annals of Pharmacotherapy
66. Exosomal delivery of cannabinoids against cancer
    Sukhmandeep Kaur, Aakash Nathani, Mandip S. Singh · 2023 · Cancer Letters
67. Medicinal Cannabis and Central Nervous System Disorders
    Yuma T. Ortiz, Lance Richard McMahon, Jenny L. Wilkerson · 2022 · Frontiers in Pharmacology
68. The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
    Ivona Maria Tudorancea, Mitică Ciorpac, Gabriela Dumitriţa Stanciu, Cătălin-Cezar Caratașu, Alina Săcărescu, Bogdan Emilian Ignat, Alexandra Burlui, Elena Rezuş, Ioana Creangă-Murariu, Teodora Alexa‐Stratulat et al. · 2022 · Biomedicines
69. Should Oncologists Recommend Cannabis?
    D. Abrams · 2019 · Current Treatment Options in Oncology
70. The overview of existing knowledge on medical cannabis plants growing
    Matěj Malík, Jiří Velechovský, Pavel Tlustoš · 2021 · Plant Soil and Environment
71. The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients
    Joshua Aviram, Gil Moshe Lewitus, Yelena Vysotski, Mahmoud Abu Amna, Anton Ouryvaev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Luiza Akria, Dimitry Goncharov et al. · 2022 · Frontiers in Pain Research
72. Pharmacological evidence of medicinal cannabis in oncology: a systematic review
    Danielle Brown, Michael Watson, Janet Margaret Schloss · 2019 · Supportive Care in Cancer
73. Medical marijuana and pain management
    Leslie Mendoza Temple · 2016 · Disease-a-Month
74. Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review
    Alexander Shustorovich, Jamie Corroon, Mark S. Wallace, Michelle Sexton · 2024 · Pain Medicine
75. Effect of wrist-ankle acupuncture therapy combined with auricular acupuncture on cancer pain: A four-parallel arm randomized controlled trial
    Liping Xu, Shi-Lai Yang, Shao-Qing Su, Bixia Huang, Xin-Mei Lan, Ru-Jie Yao · 2020 · Complementary Therapies in Clinical Practice
76. Update on cannabis and cannabinoids for cancer pain
    Matthew J. Chung, Hee Kee Kim, Salahadin Abdi · 2020 · Current Opinion in Anaesthesiology
77. Medical cannabis is effective for cancer-related pain: Quebec Cannabis Registry results
    Saro Aprikian, Popi Kasvis, MariaLuisa Vigano, Yasmina Hachem, Michelle Canac‐Marquis, Antonio Angelo Luciano Vigano · 2023 · BMJ Supportive & Palliative Care
78. Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts
    Gérard Mick, Pascal Douek · 2024 · Pain and Therapy
79. Cancer Pain Management: What’s New?
    Jan Gaertner, Christine Schießl · 2013 · Current Pain and Headache Reports
80. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Sirichai Chayasirisobhon · 2019 · PubMed
81. In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center
    Nirupa Jaya Raghunathan, Jessica Brens, Swetha Vemuri, Qing S. Li, Jun J. J. Mao, Deborah R. Korenstein · 2022 · Supportive Care in Cancer
82. Medical Cannabis: A Review from the American Society of Pain and Neuroscience
    Natalie H. Strand, Ryan Steven D'Souza, Jay V. Karri, Hemant Kalia, Jacqueline S. Weisbein, Brian J Kassa, Nasir Hussain, Ahish Chitneni, Ryan R. Budwany, Jonathan Michael Hagedorn et al. · 2023 · Journal of Pain Research
83. Cannabis-related cognitive impairment
    Gil Bar‐Sela, Dina Tauber, Inbal Mitnik, Hedva Sheinman‐Yuffe, Tatiana Bishara-Frolova, Judith Aharon‐Peretz · 2018 · Anti-Cancer Drugs
84. Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials
    José María Prieto González, Carlos Vila Silván · 2021 · Expert Review of Neurotherapeutics
85. Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials
    Nazeer Hasan, Mohammad Imran, Afsana Sheikh, Suma Saad, Gaurav Chaudhary, Gaurav Kumar Jain, Prashant Kesharwani, Farhan Jalees Ahmad · 2022 · Journal of drug targeting
86. Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain
    Stephen John Clarke, Belinda Butcher, Andrew J. McLachlan, Jeremy David Henson, David Rutolo, Sean Hall, Luis Vitetta · 2022 · PLoS ONE
87. Chronic pain and cannabinoids. Great expectations or a christmas carol
    David Pascual, Eva Sánchez-Robles, Miguel M. García, Carlos Goicoechea · 2018 · Biochemical Pharmacology
88. Chronic and Refractory Pain: A Systematic Review of Pharmacologic Management in Oncology
    Jeannine M. Brant, Lisa Keller, Karen McLeod, Chao Hsing Yeh, Linda H. Eaton · 2017 · Clinical journal of oncology nursing
89. Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors
    Srinagesh Mannekote Thippaiah, Sloka S. Iyengar, K. Yaragudri Vinod · 2021 · Frontiers in Psychiatry
90. Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence
    Kawthar Safi, Jan Sobieraj, Michał Błaszkiewicz, Joanna Żyła, Bartłomiej Salata, Tomasz Dzierżanowski · 2024 · Biomedicines
91. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies
    Ziva D. Cooper, Donald I. Abrams · 2019 · The American Journal of Drug and Alcohol Abuse
92. Cannabinoids in the Treatment of Back Pain
    Teddy E. Kim, Robert Kyle Townsend, Charles L. Branch, Edgar Alfonso Romero-Sandoval, Wesley Hsu · 2020 · Neurosurgery
93. Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro
    Georg Richtig, Melanie Kienzl, Sonja Rittchen, David Roula, Jürgen Eberle, Zina Sarif, Martin Pichler, Gerald Höefler, Ákos Heinemann · 2023 · Biology
94. Navigating Blind in the Green Rush: Clinical Considerations and Harm Reduction Practices for Cannabis
    Brienna N. Meffert, Danielle M. Morabito, Michelle K. Mosich, Mallory Loflin, James E. Sottile, Adrienne J. Heinz · 2018 · Current Drug Research Reviews
95. A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults
    Reham Haleem, Robert C. Wright · 2020 · Journal of Clinical Medicine Research
96. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
    Mahmoud Abu-Amna, Talal Salti, Mona Khoury, Idan Cohen, Gil Bar‐Sela · 2021 · Current Treatment Options in Oncology
97. Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis
    Vera Belgers, Jantine Geertruida Röttgering, Linda Douw, Martin Klein, Johannes C. F. Ket, Peter M. van de Ven, Thomas D. Wurdinger, Myra Ellen Van Linde, Johanna M. Niers, Markus Weber et al. · 2022 · Cannabis and Cannabinoid Research
98. Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review
    Sattar Ostadhadi, Mahdieh Rahmatollahi, Ahmad Reza Dehpour, Reza Rahimian · 2014 · Phytotherapy Research
99. The endocannabinoid system: Novel targets for treating cancer induced bone pain
    Jia Sun, Ya‐Qun Zhou, Shuping Chen, Xiaomei Wang, Bingyang Xu, Danyang Li, Yuke Tian, Dawei Ye · 2019 · Biomedicine & Pharmacotherapy
100. Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
     Marta Vázquez, Carlos García‐Carnelli, Cecilia Maldonado, Pietro L. Fagiolino · 2021 · Advances in experimental medicine and biology